Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06135870 · ClinicalTrials.gov registry record
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
A clinical trial of Leiomyoma and Fibroid, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06135870 is a study of Leiomyoma and Fibroid that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 150 participants, above the 87-participant average among 8 other Leiomyoma trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06135870, a study of Leiomyoma and Fibroid, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are evaluating the role of senescent cells in uterine fibroids.
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06135870
The ClinicalTrials.gov registry entry for NCT06135870 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 8 other Leiomyoma trials with a reported enrollment target (72% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Leiomyoma appearing as the primary indexed condition, and to 0 interventions.
NCT06135870 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06135870 about?
NCT06135870 is a clinical study titled "Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)". The investigators are evaluating the role of senescent cells in uterine fibroids.
What is the current status of trial NCT06135870?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2023-11-01. Estimated completion is 2027-12-31.
What conditions does trial NCT06135870 study?
This clinical trial studies the following conditions: Leiomyoma, Fibroid.
Who is sponsoring clinical trial NCT06135870?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06135870 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leiomyoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
Effects of Simvastatin on Uterine Leiomyoma Size
RECRUITING · Phase 2
-
Prescription of Letrozole for Uterine Myoma
RECRUITING · Phase 4
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
COMPLETED · Phase 2
-
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.